Department of Neuroanesthesia-Neurointensive Care, University of Brescia, Spedali Civili, Brescia, Italy.
J Neurosurg Anesthesiol. 2012 Jan;24(1):3-8. doi: 10.1097/ANA.0b013e318224030a.
Continuous assessment of the cerebrovascular autoregulation (CVA) through use of the pressure reactivity index (PRx), a moving linear correlation coefficient between mean arterial blood pressure and intracranial pressure, has been effective in optimizing cerebral perfusion pressure (CPPopt) in traumatic brain injured (TBI) patients. This study investigates the feasibility of measuring CPPopt in patients with aneurysmal subarachnoid hemorrhage (aSAH) by continuously assessing the CVA.
Twenty-nine aSAH patients were enrolled, and data from CVA status, CPPopt, and periods when CPP was below, within, or above CPPopt were computed daily. Outcome was assessed at 6 months with the Glasgow Outcome Scale. Mann-Whitney U test was used to analyze differences in the duration of impaired CVA and duration of CPP below CPPopt in patients with good and poor outcomes. Multivariable logistic regression analysis was used to identify independent predictors of outcome.
CVA monitoring data were available for all 29 patients with a total monitoring time of 2757 h. The duration of impaired CVA was 36.5% (interquartile range: 24.6 to 49.8) of the total monitoring time in 15 patients with good outcome and 71.6% of the total monitoring time (51.2 to 80.0) in 14 patients with poor outcome (Mann-Whitney U test 3.295, P=0.0010). PRx-based CPPopt could be identified in 26 patients (89.6%) with a total monitoring time of 2691 h. The duration of CPP below the CPPopt range was 28.0% (interquartile range: 18.0 to 47.0) of the total monitoring time in patients with good outcome and 76.0% (48.5 to 82.5) in patients with poor outcome (Mann-Whitney U test 2.779, P=0.0054). Glasgow Coma Scale score and duration of impaired CVA were independently associated with 6-month outcome (Glasgow Coma Scale score odds ratio: 1.95, 95% confidence interval: 1.01-3.75; duration of impaired CVA odds ratio: 0.88, 95% confidence interval: 0.78-0.99).
The assessment of CVA and CPPopt is feasible in aSAH patients and may provide important information regarding long-term outcome. A PRx above the 0.2 threshold and a CPP below the CPPopt range are associated with worse outcome.
通过使用压力反应性指数(PRx)连续评估脑血管自动调节(CVA),可以有效地优化创伤性脑损伤(TBI)患者的脑灌注压(CPPopt)。本研究通过连续评估 CVA 来测量蛛网膜下腔出血(aSAH)患者的 CPPopt 的可行性。
共纳入 29 例 aSAH 患者,计算了 CVA 状态、CPPopt 以及 CPP 低于、等于和高于 CPPopt 的时间段。采用格拉斯哥结局量表(GOS)在 6 个月时评估预后。采用 Mann-Whitney U 检验分析预后良好和不良患者的 CVA 受损时间和 CPP 低于 CPPopt 的时间。采用多变量逻辑回归分析识别预后的独立预测因素。
所有 29 例患者均有 CVA 监测数据,总监测时间为 2757 小时。15 例预后良好患者的 CVA 受损时间占总监测时间的 36.5%(四分位距:24.6 至 49.8),14 例预后不良患者的 CVA 受损时间占总监测时间的 71.6%(51.2 至 80.0)(Mann-Whitney U 检验 3.295,P=0.0010)。在 26 例(89.6%)患者中可以识别基于 PRx 的 CPPopt,总监测时间为 2691 小时。预后良好患者的 CPP 低于 CPPopt 范围的时间占总监测时间的 28.0%(四分位距:18.0 至 47.0),预后不良患者的 CPP 低于 CPPopt 范围的时间占总监测时间的 76.0%(48.5 至 82.5)(Mann-Whitney U 检验 2.779,P=0.0054)。格拉斯哥昏迷量表评分和 CVA 受损时间与 6 个月时的预后独立相关(格拉斯哥昏迷量表评分比值比:1.95,95%置信区间:1.01-3.75;CVA 受损时间比值比:0.88,95%置信区间:0.78-0.99)。
在 aSAH 患者中评估 CVA 和 CPPopt 是可行的,可能为长期预后提供重要信息。PRx 高于 0.2 阈值和 CPP 低于 CPPopt 范围与预后不良相关。